Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm D Mason

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
European Urology|May 8, 2019
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United KingdomDavid W Donnelly, Anna Gavin, Amy Downing, et al.
European Urology|October 11, 2014
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)Nicholas David James, Melissa R Spears, Noel W Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2015
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate CancerMalcolm D Mason, Wendy R Parulekar, Matthew R Sydes, et al.
JCO Precision Oncology|January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE TrialClare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
JAMA Oncology|November 26, 2015
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE TrialNicholas D James, Melissa R Spears, Noel W Clarke, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
European Urology|August 1, 2017
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewMichael Lardas, Matthew Liew, Roderick C van den Bergh, et al.
BJU International|March 1, 2018
Urinary, bowel and sexual health in older men from Northern IrelandDavid W Donnelly, Conan Donnelly, Therese Kearney, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
European Urology|May 8, 2019
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United KingdomDavid W Donnelly, Anna Gavin, Amy Downing, et al.
European Urology|October 11, 2014
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)Nicholas David James, Melissa R Spears, Noel W Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2015
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate CancerMalcolm D Mason, Wendy R Parulekar, Matthew R Sydes, et al.
JCO Precision Oncology|January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE TrialClare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
JAMA Oncology|November 26, 2015
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE TrialNicholas D James, Melissa R Spears, Noel W Clarke, et al.
European Urology|December 23, 2015
Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic ReviewRoderick C N van den Bergh, Niels J van Casteren, Thomas van den Broeck, et al.
European Urology|August 30, 2016
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
JAMA|April 6, 2024
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical TrialRichard M Martin, Emma L Turner, Grace J Young, et al.
European Urology|August 1, 2017
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic ReviewMichael Lardas, Matthew Liew, Roderick C van den Bergh, et al.
BJU International|March 1, 2018
Urinary, bowel and sexual health in older men from Northern IrelandDavid W Donnelly, Conan Donnelly, Therese Kearney, et al.
Pageof 15